Chemical structure of molecule "compound 44" Merck bicyclic macrocyclic peptide PCSK9 inhibitor

bioavailable bicyclic macrocycle PCSK9 inh.

%F cyno = 2.9, MW 1612, preclinical

from mRNA display screen and SBDD

Journal of Medicinal Chemistry

Merck & Co.

The Merck bicyclic macrocyclic peptide PCSK9 inhibitor, “compound 44,” is a highly potent (Ki = 0.00239 nM) and orally bioavailable (cyno %F = 2.9, t1/2 = 10 h) agent…


 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.